Project Grant HT94252410166
Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $2.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10012, USA
Similar Awards
- The U.S. Defense Health Agency awarded a $818,929 Project Grant to New York University (NYU) to implement a formal postvention program for military mental health clinicians. The grant was awarded on September 30, 2025 under the Military Medical Research and Development program (CFDA 12.420) and has an ultimate completion date of September 29, 2029. The project aims to transform healthcare for military service members, veterans, and the broader public by developing novel diagnostic tools,...
- The Department of Defense's Defense Health Agency awarded a $791,063 Project Grant to New York University (NYU) to Implement a Formal Postvention Program for Military Mental Health Clinicians. This grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant will run from September 30, 2025 through September 29, 2029,...
- This $2,013,978 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by New York University School of Medicine. The research aims to investigate the metabolic dysregulation and disease mitigation effects of targeting the RAGE protein after particulate matter exposure. The 3-year award period runs from July 1, 2025 to June 30, 2028 and will fund specialized scientific investigations in this...
- The Defense Health Agency awarded a $1,694,245 Project Grant to New York University (NYU) School of Medicine, a private non-profit research institution and medical school, to develop innovative therapeutics against pressure ulcer-associated bacteria. The 4-year grant, which runs from August 2023 to August 2027, is funded under the Military Medical Research and Development program (CFDA 12.420). Through this award, NYU School of Medicine will conduct research to identify and advance new...
- This Project Grant award from the Defense Health Agency provides $1,077,570.00 to New York University (NYU) to develop a state-of-the-art microbur-driven non-absorbable epithelial SERT antagonist to treat anxiety and depression in military members and the general public. The award is funded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public through...
- The Defense Health Agency awarded a $749,343 Project Grant to New York University (NYU) under the Military Medical Research and Development program (CFDA 12.420) to support "P15-1 PEPTIDE TREATMENT FOR CARTILAGE INJURIES AND POST-TRAUMATIC OSTEOARTHRITIS". The award has a performance period from August 1, 2025 to July 31, 2027. As a leading academic medical center and research institution, NYU will use this funding to conduct advanced biomedical research focused on developing...
- This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
- New York University School of Medicine was awarded a $762,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project titled "BEYOND VEXAS AND UBA1: IDENTIFICATION OF NOVEL DRIVERS OF MDS AUTOIMMUNE SYNDROMES" from June 15, 2023 through June 14, 2026. The grant supports research to identify novel drivers of myelodysplastic syndromes, blood disorders that can progress...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- The U.S. Defense Health Agency awarded a $650,000 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public, with a focus on psychiatric aspects of post-traumatic epilepsy. The 3-year project, beginning April 15, 2025 and...